1Vestbo J, Agusti A, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease [EB/OL ]. http: // www. goldcopd, org, 2009.
2Frans H, Rutten, Maarten-Jan M, et al. Heart failure and chronic obstructive pulmonary disease: An ignored combination [J]. European Journal of Heart Failure, 2006, 8: 706--711.
3Schwam E. B-type natriuretie peptide for diagnosis of heart failure in emergency department patients: a critical appraisal [J]. AcadEmerg-Med, 2004, 11 (6): 686--691.
4Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases [J]. Congest Heart Fail, 2004, 10 (suppl3): 1--30.
5Yap LB, Mukerjee D, Timms PM, et al. Natriuretic peptides, respiratory disease, and the right heart [J]. Chest, 2004, 126 (4): 1330--1336.
6Georg-Christian F, Irene L, Peter S, et al. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure[J]. Chest, 2008, 133 (6): 1354--1359.
7Ozer N, Tokgozoglu L, Coplu L, et al. Echocardiographic evaluation of left and right ventricular diastolic function in patients with chronic obstructive pulmonary disease [J].J Am Soe Echocardiogr, 2001, 14 (16): 557--561.
8Boussuges A, Pinet C, Molenat H, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease: an echocardiographic and Doppler study [J]. Am J Respir Crit Care Med, 2000, 162 (2):670--675.
9Amlov J, Lind L, Andren B, et al. A Doppler-derived index of combined left ventricular systolic and diastolic function is an independent predictor of cardiovascular mortality in elderly men [J]. Am Heart J, 2005, 149 (5): 902-907.
10Dodos F, Hslbsguth T, Erdmann E, et al. Usefulness of myocardial performance index and bioehemical markers for early detection of anthracycline--induced cardiotoxieity in adults [J]. Clin Res Cardiol, 2008, 97 (5): 318--326.
